IRADIMED CORPORATION Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	89.34	83.81	73.24	65.56	53.3	41.81
Revenue Growth	10.97%	14.43%	11.71%	23.00%	27.47%	31.84%
Cost of Revenue	21.88	19.49	16.89	15.4	12.02	9.76
Gross Profit	67.46	64.32	56.35	50.16	41.28	32.05
Selling, General & Admin	35.34	35.23	31.59	27.3	23.41	20.36
Research & Development	3.26	2.95	2.8	2.82	2.24	1.87
Operating Expenses	38.6	38.18	34.39	30.12	25.65	22.23
Operating Income	28.86	26.15	21.97	20.04	15.63	9.82
Interest & Investment Income	2.01	2.01	2.19	1.86	0.58	0.03
Currency Exchange Gain (Loss)	0	0	-0.04	-0.15	-0.04	-0.03
Other Non Operating Income (Expenses)	0.04	-	0.16	-	-	-
EBT Excluding Unusual Items	30.91	28.16	24.28	21.75	16.17	9.82
Gain (Loss) on Sale of Investments	-	-	-	-	0.01	0.02
Gain (Loss) on Sale of Assets	0.2	0.2	-0	-0.01	-	-
Pretax Income	31.12	28.36	24.28	21.74	16.18	9.84
Income Tax Expense	7.13	5.88	5.04	4.55	3.35	0.51
Net Income	23.98	22.48	19.23	17.19	12.83	9.33
Net Income to Common	23.98	22.48	19.23	17.19	12.83	9.33
Net Income Growth	13.21%	16.88%	11.87%	34.02%	37.56%	581.19%
Shares Outstanding (Basic)	13	13	13	13	13	12
Shares Outstanding (Diluted)	13	13	13	13	13	13
Shares Change	0.26%	0.55%	0.48%	0.69%	0.36%	1.21%
EPS (Basic)	1.88	1.77	1.52	1.36	1.02	0.76
EPS (Diluted)	1.87	1.75	1.50	1.35	1.02	0.74
EPS Growth	13.33%	16.67%	11.11%	32.35%	37.84%	572.73%

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	26.14	17.18	17.62	6.02	9.22	10.78
Free Cash Flow Per Share	2.03	1.34	1.38	0.47	0.73	0.86
Dividend Per Share	0.800	0.710	0.470	0.150	-	-
Dividend Growth	17.65%	51.06%	213.33%	-	-	-
Gross Margin	75.51%	76.75%	76.94%	76.50%	77.45%	76.65%
Operating Margin	32.30%	31.20%	29.99%	30.56%	29.32%	23.48%
Profit Margin	26.85%	26.82%	26.26%	26.22%	24.07%	22.30%
Free Cash Flow Margin	29.26%	20.50%	24.06%	9.19%	17.30%	25.77%
EBITDA	30.52	27.31	22.78	20.8	16.3	11.22
EBITDA Margin	34.16%	32.59%	31.11%	31.73%	30.58%	26.84%
D&A For EBITDA	1.66	1.17	0.82	0.77	0.67	1.41
EBIT	28.86	26.15	21.97	20.04	15.63	9.82
EBIT Margin	32.30%	31.20%	29.99%	30.56%	29.32%	23.48%
Effective Tax Rate	22.92%	20.74%	20.77%	20.91%	20.72%	5.19%

SEC Filings: 10-K · 10-Q